CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immune competent, chemoresistant neuroblastoma preclinical models
Courtney Himsworth, Thomas John Jackson, Chantelle E Bowers, Sophie Munnings-Tomes, Gaya Nair, Henrike P. Muller, Elizabeth Tucker, Amy K Erbe-Gurel, PaulM. Sondel, Louis Chesler, Robbie Mazjner, John Anderson
This study shows CD47 blockade enhances anti-GD2 phagocytosis in vitro but does not improve in vivo efficacy in neuroblastoma models.
PLoS ONE · Oct 27, 2026Peer-reviewedImmunology